Ibaraki, Japan

Kazuo Koshiya

This inventor holds 1 USPTO granted patent. Top assignee: Yamanouchi Pharmaceutical Company Ltd.. Active years: 1998.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kazuo Koshiya. Retrieved from https://idiyas.com/inventor/kazuo-koshiya

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 1998

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Kazuo Koshiya – Pioneer in Serine Derivatives

Introduction

Kazuo Koshiya, an esteemed inventor based in Ibaraki, Japan, has made significant contributions to the pharmaceutical field through his innovative research and development. With a keen focus on enhancing the efficacy of chemical compounds, he has secured a patent for a novel serine derivative.

Latest Patents

Koshiya holds one patent related to the synthesis and application of a serine derivative. This advancement plays a crucial role in the pharmaceutical industry by potentially improving therapeutic options and treatment formulations.

Career Highlights

Currently, Kazuo Koshiya is affiliated with Yamanouchi Pharmaceutical Company Ltd., where he leverages his expertise to advance pharmaceutical science. His work reflects a commitment to innovation and the development of new medicinal compounds.

Collaborations

Throughout his career, Koshiya has collaborated with notable colleagues, including Ichio Noda and Masahiro Iwata. Together, they have fostered an environment of creativity and research excellence that contributes to the ongoing advancement of pharmaceuticals.

Conclusion

Kazuo Koshiya's contributions to the field of pharmaceuticals, particularly through his patented serine derivative, highlight the importance of innovation in medicine. His collaborative efforts and dedication to research continue to make an impact on the industry and pave the way for future advancements.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…